Patent 7160873 was granted and assigned to Pharmacyclics on January, 2007 by the United States Patent and Trademark Office.
Novel coordination polymers, their pharmaceutical formulations, useful for treating atheroma, tumors and other neoplastic tissue, as well as other conditions that are responsive to the induction of targeted oxidative stress, are disclosed.